NEXGEL, Inc. (NXGL) Stock

NEXGEL, Inc. specializes in the manufacturing of advanced hydrogels and gels characterized by high water content and electron beam cross-linking technology. These innovative products find applications across diverse sectors including wound care, medical diagnostics, transdermal drug delivery, and cosmetics. Originally established as AquaMed Technologies, Inc., the company rebranded to NEXGEL, Inc. in November 2019, reflecting its evolution and commitment to pioneering hydrogel solutions.

Founded in 1997 and headquartered in Langhorne, Pennsylvania, NEXGEL, Inc. has established itself as a leader in the field of aqueous polymer technologies. The company's expertise lies in developing specialized formulations that enhance therapeutic outcomes and improve patient care across various healthcare disciplines. By leveraging cutting-edge electron beam cross-linking techniques, NEXGEL continues to innovate and expand its product offerings to meet the evolving needs of the medical and cosmetic industries.

Beyond its core manufacturing capabilities, NEXGEL remains dedicated to advancing hydrogel technology through ongoing research and development initiatives. This commitment underscores its role as a trusted partner for healthcare professionals seeking reliable and effective solutions for wound healing, diagnostic applications, and beyond. With a focus on quality, innovation, and customer satisfaction, NEXGEL continues to drive forward as a leading provider of advanced hydrogel products globally.